sharecast

{{ storiesRelated.title }}

Company News
09 May
dl rotala aim bus operator passenger transport public transit buses greater manchester franchise logo
Rotala profits improve as bus market recovers post-Covid

Bus-focussed passenger transport operator Rotala reported total revenue of £84. 9m in its final results for 2022 on Tuesday, down from £96. 5m in the prior year, but up from £78. 1m in 2020.

09 May
dl treatt plc food ingredients maker manufacturer beverage flavours producer logo
Treatt hails record first-half revenues

Ingredients manufacturer Treatt hailed record first-half revenues on Tuesday, with growth across the product portfolio.

09 May
Marshalls shares slump on guidance cut as LFL sales fall

Shares in Marshalls slumped on Tuesday as the landscaping and building materials group cut annual guidance on the back of a 14% fall in like-for-like sales, due to lower new house building and continued weakness in private housing maintenance activity.

09 May
dl enquest energy oil gas producer production logo
EnQuest inks deal with Malaysian state energy firm Petronas

Oil and gas producer EnQuest has signed an agreement with Malaysian state-owned energy company Petronas, it announced on Tuesday, on behalf of the PM8 Extension production sharing contract (PSC) parties.

09 May
dl petards group plc aim industrials industrial goods and services industrial support services professional business support services logo 20230509 1420
Petards Group revenue, earnings fall in 2022

Security and surveillance technology specialist Petards Group reported total revenues of £10. 87m in its final results on Tuesday, down from £13. 57m in 2021.

09 May
dl de la rue banknote security printining authentication currency technology provider logo
De La Rue delays full-year results by a month

De La Rue updated the market on the timing of its results for the year ended 25 March on Tuesday, confirming they would be delayed until late June.

09 May
dl victrex polymers engineering specialty chemicals plastics products logo ftse 250
Victrex gross profit rises, macro weakness remains a challenge

Polymer specialist Victrex reported a 1% improvement in first-half revenue in its interim results on Tuesday, to £162. 2m, with gross profit increasing 2% to £86. 7m, although macroeconomic weakness was proving a challenge.

09 May
dl dcc flogas truck lorry tanker gas energy transport ftse 100 min
DCC chief executive to step back to address medical condition

Sales, marketing and support services group DCC said on Tuesday that chief executive Donal Murphy will step back from his day-to-day responsibilities for the next few weeks to address a medical condition.

09 May
dl fresnillo plc fres basic materials basic resources precious metals and mining gold mining ftse 100 premium 20230328 1811
Fresnillo expects minimal impact from Mexico mining law reform

Fresnillo updated the market on Mexico's reformed federal mining law on Tuesday, claiming that its potential impact on current operations and exploration projects would be minimal.

09 May
Diversified Energy says Q1 trading in line

Diversified Energy said it was trading in line with expectations after recording average first quarter production of 139 million barrels of oil per day.

09 May
dl kosmos energy ltd lse energy energy oil gas and coal oil crude producers logo 20230509 0824
Kosmos Energy reports progress in first quarter

Oil and gas explorer and producer Kosmos Energy reported first-quarter net income of $83m on Tuesday, or 17 US cents per diluted share.

09 May
Urban Logistics agrees 15 new lettings in Q1

Urban Logistics REIT said it had agreed 15 new lettings in the first quarter, generating £1. 6m of additional rental income.

09 May
dl jd sports fashion plc jd consumer discretionary retail retailers apparel retailers ftse 100 premium 20230403 1249
JD Sports to buy France's Courir in €520m deal

JD Sports said on Tuesday that it has agreed to buy French sportswear retailer Courir in a €520m deal.

09 May
AstraZeneca's Farxiga heart failure drug gets extended US approval

AstraZeneca's Farxiga drug has been approved in the US to reduce the risk of cardiovascular death, hospitalisation for heart failure and urgent heart failure visits in adults, the company said on Tuesday.